Beginning Dec. 1, 2024, we will require notification/prior authorization for the following specialty medications for UnitedHealthcare Community Plan (Medicaid) members in Maryland:
| Drug name | HCPCS code (s) | 
|---|---|
| Abecma® (idecabtagene vicleucel) | Q2055 | 
| Acthar® Gel (repository corticotropin injection) | J0801 | 
| Adzynma™ (ADAMTS13, recombinant-krhn) | J7171 | 
| Amondys 45® (casimersen) | J1426 | 
| Breyanzi® (lisocabtagene maraleucel) | Q2054 | 
| Carvykti™ (ciltacabtagene autoleucel) | Q2056 | 
| Cortrophin® Gel (repository corticotropin injection) | J0802 | 
| Cosentyx® IV (secukinumab) | J3247 | 
| Elevidys™ (delandistrogene moxeparvovec-rokl) | J1413 | 
| Elfabrio® (pegunigalsidase alfa-iwxj) | J2508 | 
| Evkeeza® (evinacumab-dgnb) | J1305 | 
| Eylea® HD (aflibercept) | J0177 | 
| Hemgenix™ (etranacogene dezaparvovec-drlb) | J1411 | 
| Lamzede® (velmanase alfa-tycv) | J0217 | 
| Omvoh™ (mirikizumab-mrkz) | J2267 | 
| Pombiliti™ (cipaglucosidase alfa-atga) | J1203 | 
| Qalsody™ (tofersen) | J1304 | 
| Roctavian™ (valoctogcogene roxaparvovec-rvox) | J1412 | 
| Rystiggo™ (rozanolixizumab-noli) | J9333 | 
| Tecartus® (brexucabtagene autoleucel) | Q2053 | 
| Veopoz™ (pozelimab-bbfg) | J9376 | 
| Vyjuvek™ (beremagene geperpavec-svdt) | J3401 | 
| Vyvgart® (efgartigimod alfa-fcab) | J9332 | 
| Vyvgart® Hytrulo™ (efgartigimd alfa and hyaluronidase-qvfc) | J9334 | 
| Zynteglo™ (betibeglogene autotemcel) | J3393 | 
You can submit a prior authorization request through the UnitedHealthcare Provider Portal:
Please note: For the following cell and gene therapies, you must contact Optum Transplant Services at 888-805-1802 to submit your prior authorization request:
If we don’t receive a prior authorization request before the date of service, we’ll deny the claim and you won’t be able to balance bill members.
Connect with us through chat 24/7 in the UnitedHealthcare Provider Portal.
PCA-1-24-02542-Clinical-NN_08162024